Mind Matters Psychiatry/ Dr Prashant Gajwani
4502 Riverstone Boulevard, Suite 601, Missouri City
4.6(97 Google reviews)
United States
1 listed treatment center serving Missouri City and the surrounding area.
4502 Riverstone Boulevard, Suite 601, Missouri City
4.6(97 Google reviews)
Every dose is given in a certified healthcare setting, followed by at least two hours of monitoring. Arrange transportation home after each visit. Distances below are straight-line miles from Missouri City.
4.2 miles away · Sugar Land
77 Sugar Creek Center Boulevard, Suite 330, Sugar Land
5.0(25 Google reviews)
7.9 miles away · Bellaire
10.2 miles away · Houston
4295 San Felipe Street, Suite 205, Houston
5.0(8 Google reviews)
10.3 miles away · Houston
3120 Southwest Freeway, Suite 617, Houston
5.0(14 Google reviews)
10.9 miles away · Houston
11.6 miles away · Houston
The cost of SPRAVATO® treatment in Missouri City depends on your insurance benefits, the treatment setting, and how services are billed. Both the medication and the visit for administration and observed monitoring may generate charges. Ask for an estimate that explains these components rather than assuming a medication copay represents the entire visit cost.
Prior authorization is common. Your insurer may request records of earlier antidepressant trials, including which medications you took and how you responded. Ask the center which records it needs, who submits the authorization, and whether approval covers both the medication and monitoring services. Confirm authorization before starting; it does not necessarily eliminate out-of-pocket costs.
Medicare coverage may fall under Part B or Part D depending on the plan and setting. Texas Medicaid coverage also depends on the applicable plan and setting. The Missouri City center currently listed in this directory is marked as not accepting Medicare or Medicaid, so confirm its current participation directly. That listing does not establish whether your benefits would cover treatment elsewhere.
Manufacturer savings programs exist for eligible commercially insured patients, but not for patients using government insurance. Ask about current eligibility rules and which charges any assistance applies to.
Before committing to treatment, ask the center and insurer:
Include transportation and time away from work in your planning, even though they are separate from treatment charges.
SPRAVATO® is given only in a healthcare setting certified through the Spravato REMS safety program. You administer the nasal spray yourself under a healthcare provider’s direct observation; it is never sent home with you. Missouri City currently has one listed center offering treatment, but its REMS certification is not confirmed in this directory. Verify certification directly before scheduling.
The typical labeled schedule starts with twice-weekly treatment during weeks 1–4, followed by weekly visits during weeks 5–8. Maintenance visits may be weekly or every two weeks. Your prescriber individualizes the schedule, so discuss your expected appointments rather than assuming a fixed long-term routine.
Plan for at least two hours of monitoring after each dose, plus time for check-in, assessment, and administration. The full appointment can therefore take longer than two hours. Ask the center how much time to reserve and whether appointment availability fits your work or caregiving responsibilities. Consider arranging time off and backup help for responsibilities after treatment.
You need someone else to drive you home. You must not drive or operate machinery until the next day after a restful sleep. Arrange transportation before each appointment, ask about the center’s pickup requirements, and have a backup plan if your driver becomes unavailable.
If the Missouri City listing cannot accommodate you—or if no local center is listed when you search—check listed options in Houston or Friendswood. Confirm their certification, availability, and insurance participation independently. Compare the practical burden of repeated trips without assuming a particular travel time, and discuss transportation barriers with the treatment team before starting.
This directory currently lists one Missouri City center offering SPRAVATO®, but its REMS certification has not been confirmed here. Contact the center to verify that it is certified and accepting new patients. If it cannot meet your needs, you can also explore listed centers in Houston or Friendswood. A directory listing alone does not verify certification, appointment availability, or insurance participation.
Spravato is approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder and acute suicidal ideation or behavior, together with an oral antidepressant. It is not approved for children. A clinician must review your diagnosis, treatment history, and medical risks to determine whether it is appropriate for you.
Coverage depends on your plan, treatment setting, and authorization requirements. Insurers commonly request documentation of previous antidepressant trials. Ask about coverage for both the medication and monitored visit. The listed Missouri City center is marked as not accepting Medicare or Medicaid; verify that directly. This does not mean those programs never cover treatment. Ask your insurer which settings may be covered under your benefits.
You use the nasal spray yourself under a healthcare provider’s direct observation in a REMS-certified setting. The team monitors you for at least two hours after the dose, including watching for sedation, dissociation, breathing problems, and blood pressure increases. Allow additional time for other appointment steps. Arrange someone else to drive you home, and do not drive until the next day after a restful sleep.
Ask about sedation, dissociation—feeling disconnected from yourself or your surroundings—respiratory depression, and increased blood pressure. Spravato carries boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Review your health history and medications with the prescriber, and tell staff promptly about symptoms during monitoring.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when clinically needed. Do not wait for a treatment appointment if you are in crisis. Call or text 988 for crisis support, or call 911 in an emergency. A clinician can assess immediate safety needs separately from decisions about ongoing depression treatment.
Approved uses, nearby treatment centers, and medically sourced patient guides.